Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2016-12-05 17:08:00
Reporting Period:
Filing Date:
Accepted Time:
2016-12-05 17:08:00
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1008848 Acorda Therapeutics Inc ACOR Biological Products, (No Disgnostic Substances) (2836) 000000000
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1272354 Ron Cohen 420 Saw Mill River Road
Ardsley NY 10502
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2016-12-01 7,160 $20.74 479,688 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 42,940 Indirect Beneficial Ownership in Trust
  1. Sales pursuant to a 10b5-1 plan. These sales are primarily intended to cover the tax liability resulting from restricted stock vesting.
  2. The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $20.30 to $21.25 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  3. 57,060 shares of Acorda Therapeutics, Inc.'s Common Stock that were distributed to the reporting person on September 8, 2016 by the reporting person's grantor retained annuity trust ("GRAT") are included in the shares reported as held directly by the reporting person. These shares were previously reported as held indirectly through the GRAT.
  4. These shares are held in the GRAT, which was established by the reporting person and of which he is the sole trustee.